ICU · Infectious Diseases
Acute severe community-acquired pneumonia: post-influenza bacterial pneumonia
Also known as Post-influenza pneumonia · Bacterial superinfection · Staphylococcal pneumonia post-influenza
Post-influenza bacterial pneumonia is a devastating complication — influenza virus damages respiratory epithelium → secondary bacterial invasion. Most common organisms: Staphylococcus aureus (1, including MRSA and PVL-positive strains — causes necrotising pneumonia with high mortality), Streptococcus pneumoniae (2), Haemophilus influenzae. Presents as: initial viral illness (fever, myalgia, cough) → transient improvement → sudden deterioration (high fever, dyspnoea, septic shock, multilobar infiltrates, cavitation). Diagnosis: influenza PCR + sputum/blood cultures + urinary antigens. Treatment: antiviral (oseltamivir) + broad-spectrum antibiotics (cover MRSA — add vancomycin/linezolid) + supportive ICU care. Mortality: 20-40%.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Deterioration after initial influenza improvement = bacterial superinfection — add anti-MRSA cover
- Post-influenza S. aureus pneumonia is often NECROTISING (cavitation on CXR) — high mortality
- PVL-positive S. aureus: causes rapidly progressive necrotising pneumonia — often young, previously healthy
- Always test for influenza in severe CAP during flu season — antivirals may reduce severity
Meet the patient
A 31-year-old previously well woman arrives in mid-winter with a seven-day influenza-like illness that had begun to clear. Overnight she spikes a high fever, coughs up blood-streaked sputum, and becomes breathless and cold. She is septic — MAP 58, HR 142, RR 36, SpO2 88 percent on 15 L — and the chest X-ray shows multilobar consolidation with early cavitation. Influenza A PCR is positive.[2]
This is the canonical post-influenza stem, and the question it plants is question whole topic answers: when does "getting better" become the most dangerous moment of the illness? The answer is the biphasic curve — the bacterial superinfection strikes just as the viral illness seems to be resolving, and the organism most likely to kill the patient is Staphylococcus aureus.[3]
[2]References23ShowHide
- [1]Niederman MS, Torres A Severe community-acquired pneumonia. Intensive care medicine, 2022.PMID 36517046
- [2]Martin-Loeches I, van Someren Gréve F, Schultz MJ Bacterial pneumonia as an influenza complication. Current opinion in infectious diseases, 2017.PMID 27984245
- [3]Morens DM, Taubenberger JK, Fauci AS Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. The Journal of infectious diseases, 2008.PMID 18710327
- [4]Rynda-Apple A, Robinson KM, Alcorn JF Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease. Infection and immunity, 2015.PMID 26216421
- [5]Sun K, Metzger DW Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nature medicine, 2008.PMID 18438414
- [6]Uyeki TM, Hui DS, Zambon M, et al. Influenza. Lancet (London, England), 2022.PMID 36030813
- [7]Uyeki TM Influenza. Annals of internal medicine, 2021.PMID 34748378
- [8]Harper SA, Bradley JS, Englund JA, et al. Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009.PMID 19281331
- [9]Engler RJM, Nelson MR Host immune responses to influenza infection and vaccines: Lessons learned for all viral pandemic challenges. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2020.PMID 32564928
- [10]Chow EJ, Doyle JD, Uyeki TM Influenza virus-related critical illness: prevention, diagnosis, treatment. Critical care (London, England), 2019.PMID 31189475
- [11]He G, Massarella J, Ward P Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clinical pharmacokinetics, 1999.PMID 10628898
- [12]Ueda T, Takesue Y, Nakajima A Vancomycin loading dose is associated with increased early clinical response without attainment of initial target trough concentration at a steady state in patients with methicillin-resistant Staphylococcus aureus infections. Journal of clinical pharmacy and therapeutics, 2020.PMID 32301537
- [13]Rybak MJ, Le J, Lodise TP Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy, 2020.PMID 32227354
- [14]Rubinstein E, Cammarata S, Oliphant T Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001.PMID 11170948
- [15]Taboada M, Melnick D, Iaconis J Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials. The Journal of antimicrobial chemotherapy, 2016.PMID 26702925
- [16]Paterson DL Clinical experience with recently approved antibiotics. Current opinion in pharmacology, 2006.PMID 16904377
- [17]Gillet Y, Issartel B, Vanhems P Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet (London, England), 2002.PMID 11888586
- [18]Anzueto A, Niederman MS, Pearle J Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006.PMID 16323095
- [19]Welliver R, Monto AS, Carewicz S Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA, 2001.PMID 11176912
- [20]American College of Obstetricians and Gynecologists ACOG Committee Opinion No. 753: Assessment and Treatment of Pregnant Women With Suspected or Confirmed Influenza. Obstetrics and gynecology, 2018.PMID 30247362
- [21]Liu C, Bayer A, Cosgrove SE Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011.PMID 21208910
- [22]Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The New England journal of medicine, 2000.PMID 10793162
- [23]Stevens DL, Ma Y, Salmi DB Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. The Journal of infectious diseases, 2007.PMID 17191165